ℹ️
🇬🇧
Search
Search for people relevant for "Cases"
Cases
Person
Class
Person
Publication
Programmes
Export current view
doc. MUDr. David Belada Ph.D.
Academic staff at Faculty of Medicine in Hradec Králové
350 publications
Publications
publication
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis
2011 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
publication
Malignant lymphomas of non-Hodgkin type in the annals in Department of Dentistry in Hradec Králové 1998-2008
2011 |
Faculty of Medicine in Hradec Králové
publication
Staging of non-Hodgkin's lymphoma - Recommendations of the Czech Lymphoma Study Group
2010 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
publication
Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: successful treatment with risk-adapted rituximab-based immunochemotherapy
2010 |
Faculty of Medicine in Hradec Králové
publication
Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: successful treatment with rituximab
2010 |
Faculty of Medicine in Hradec Králové
publication
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study
2024 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
publication
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
publication
Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first-line therapy administration in patients with chronic lymphocytic leukemia
2023 |
Faculty of Medicine in Hradec Králové
Load more publications (340)
Loading network view...